250 related articles for article (PubMed ID: 1472082)
1. The enzymology of doxorubicin quinone reduction in tumour tissue.
Cummings J; Allan L; Willmott N; Riley R; Workman P; Smyth JF
Biochem Pharmacol; 1992 Dec; 44(11):2175-83. PubMed ID: 1472082
[TBL] [Abstract][Full Text] [Related]
2. NAD(P)H: quinone oxidoreductase (DT-diaphorase) in chick embryo liver. Comparison to activity in rat and guinea pig liver and differences in co-induction with 7-ethoxyresorufin deethylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Spencer CB; Rifkind AB
Biochem Pharmacol; 1990 Jan; 39(2):327-35. PubMed ID: 2105732
[TBL] [Abstract][Full Text] [Related]
3. The consequences of doxorubicin quinone reduction in vivo in tumour tissue.
Cummings J; Willmott N; Hoey BM; Marley ES; Smyth JF
Biochem Pharmacol; 1992 Dec; 44(11):2165-74. PubMed ID: 1472081
[TBL] [Abstract][Full Text] [Related]
4. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
Walton MI; Smith PJ; Workman P
Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
[TBL] [Abstract][Full Text] [Related]
5. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
[TBL] [Abstract][Full Text] [Related]
6. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
[TBL] [Abstract][Full Text] [Related]
7. Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450.
Dutton DR; Parkinson A
Arch Biochem Biophys; 1989 Feb; 268(2):617-29. PubMed ID: 2536534
[TBL] [Abstract][Full Text] [Related]
8. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
Aiyar J; De Flora S; Wetterhahn KE
Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126
[TBL] [Abstract][Full Text] [Related]
9. Sex-dependent activities of quinone reductases in rabbits indicate higher risk of bladder cancer in the male.
Mohandas J; Chennell AF; Duggin GG; Horvath JS; Tiller DJ
Carcinogenesis; 1986 Mar; 7(3):353-6. PubMed ID: 2419007
[TBL] [Abstract][Full Text] [Related]
10. Enzymology of mitomycin C metabolic activation in tumour tissue. Characterization of a novel mitochondrial reductase.
Spanswick VJ; Cummings J; Smyth JF
Biochem Pharmacol; 1996 Jun; 51(12):1623-30. PubMed ID: 8687477
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers.
Shimada H; Hirai K; Simamura E; Pan J
Arch Biochem Biophys; 1998 Mar; 351(1):75-81. PubMed ID: 9500851
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
Zbaida S; Levine WG
Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
[TBL] [Abstract][Full Text] [Related]
13. Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin.
Walton MI; Workman P
Biochem Pharmacol; 1990 Jun; 39(11):1735-42. PubMed ID: 2344370
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
Joseph P; Jaiswal AK
Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
[TBL] [Abstract][Full Text] [Related]
15. Vanadate-dependent NAD(P)H oxidation by microsomal enzymes.
Reif DW; Coulombe RA; Aust SD
Arch Biochem Biophys; 1989 Apr; 270(1):137-43. PubMed ID: 2494940
[TBL] [Abstract][Full Text] [Related]
16. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition.
Preusch PC; Smalley DM
Free Radic Res Commun; 1990; 8(4-6):401-15. PubMed ID: 2113031
[TBL] [Abstract][Full Text] [Related]
18. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
[TBL] [Abstract][Full Text] [Related]
19. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
[TBL] [Abstract][Full Text] [Related]
20. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
